Immusoft (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Economics, Econometrics and Finance 4.8×
• Biochemistry, Genetics and Molecular Biology 3.7×
• Medicine 3.1×
• Social Sciences 0.8×

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Nanoparticles, Parkinson's Disease, Enzyme Replacement Therapy, Lysosomal Storage Disorders, RNA Interference, siRNA Delivery and DNA nanotechnology.

By volume in 2022–2025: Glycogen Storage Diseases and Myoclonus, Trypanosoma species research and implications, Lysosomal Storage Disorders Research and Diverse academic and cultural studies.

1. 1 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
2. 2 Trypanosoma species research and implications Epidemiology 0 works
3. 3 Lysosomal Storage Disorders Research Physiology 0 works
4. 4 Diverse academic and cultural studies Economics and Econometrics 0 works
5. 5 Diabetes and associated disorders Genetics 0 works
6. 6 Pancreatic function and diabetes Surgery 0 works
7. 7 Historical and Environmental Studies Sociology and Political Science 0 works
8. 8 Genetic Associations and Epidemiology Genetics 0 works
9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
10. 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 15% higher than in 2013–2017.

• University of Washington
• Seattle University
• Fred Hutch Cancer Center
• University of Washington Medical Center
• University of Washington Applied Physics Laboratory
• Seattle Children's Hospital
• Amazon (United States)
• Virginia Mason Medical Center